Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Colorcon
Teva
Dow
Cerilliant
Argus Health
Medtronic
Cantor Fitzgerald
Harvard Business School

Generated: May 20, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR METOPROLOL SUCCINATE

« Back to Dashboard

Clinical Trials for METOPROLOL SUCCINATE

Trial ID Title Status Sponsor Phase Summary
NCT00000499 Systolic Hypertension in the Elderly Program (SHEP) (Pilot Study) Completed National Institute on Aging (NIA) Phase 2 The SHEP Pilot Study had six objectives, each designed to develop and test critical components of a full scale trial directed at the health consequences of treating isolated systolic hypertension (ISH) in the elderly. l. To estimate and compare the yield of participants for randomization into a clinical trial from various community groups using various recruitment techniques. 2. To estimate compliance with the visit schedule and to the prescribed double-blind regimens. 3. To estimate and compare the effectiveness of specified antihypertensive medications in reducing the blood pressure. 4. To estimate and compare the unwanted effects of specified antihypertensive medication in an elderly population. 5. To evaluate the feasibility and effectiveness of periodic behavioral assessment in this population. 6. To develop and test methods of ascertaining stroke and other disease endpoints.
NCT00000499 Systolic Hypertension in the Elderly Program (SHEP) (Pilot Study) Completed National Heart, Lung, and Blood Institute (NHLBI) Phase 2 The SHEP Pilot Study had six objectives, each designed to develop and test critical components of a full scale trial directed at the health consequences of treating isolated systolic hypertension (ISH) in the elderly. l. To estimate and compare the yield of participants for randomization into a clinical trial from various community groups using various recruitment techniques. 2. To estimate compliance with the visit schedule and to the prescribed double-blind regimens. 3. To estimate and compare the effectiveness of specified antihypertensive medications in reducing the blood pressure. 4. To estimate and compare the unwanted effects of specified antihypertensive medication in an elderly population. 5. To evaluate the feasibility and effectiveness of periodic behavioral assessment in this population. 6. To develop and test methods of ascertaining stroke and other disease endpoints.
NCT00000560 Beta-Blocker Evaluation in Survival Trial (BEST) Completed National Heart, Lung, and Blood Institute (NHLBI) Phase 3 To determine if addition of a beta-blocker to standard therapy in Class III and Class IV heart failure patients reduced total mortality.
NCT00000579 Acute Respiratory Distress Syndrome Clinical Network (ARDSNet) Completed National Heart, Lung, and Blood Institute (NHLBI) Phase 3 The purposes of this study are to assess rapidly innovative treatment methods in patients with adult respiratory distress syndrome (ARDS) as well as those at risk of developing ARDS and to create a network of interactive Critical Care Treatment Groups (CCTGs) to establish and maintain the required infrastructure to perform multiple therapeutic trials that may involve investigational drugs, approved agents not currently used for treatment of ARDS, or treatments currently used but whose efficacy has not been well documented.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Clinical Trial Conditions for METOPROLOL SUCCINATE

Condition Name

Condition Name for METOPROLOL SUCCINATE
Intervention Trials
Hypertension 49
Healthy 25
Major Depressive Disorder 17
Overactive Bladder 14
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for METOPROLOL SUCCINATE
Intervention Trials
Hypertension 41
Urinary Bladder, Overactive 30
Depressive Disorder, Major 24
Depressive Disorder 24
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for METOPROLOL SUCCINATE

Trials by Country

Trials by Country for METOPROLOL SUCCINATE
Location Trials
Canada 72
China 51
Japan 33
United Kingdom 24
Netherlands 23
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for METOPROLOL SUCCINATE
Location Trials
Florida 57
Texas 56
New York 49
California 47
Ohio 47
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for METOPROLOL SUCCINATE

Clinical Trial Phase

Clinical Trial Phase for METOPROLOL SUCCINATE
Clinical Trial Phase Trials
Phase 4 89
Phase 3 83
Phase 2/Phase 3 7
[disabled in preview] 25
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for METOPROLOL SUCCINATE
Clinical Trial Phase Trials
Completed 198
Recruiting 36
Terminated 23
[disabled in preview] 20
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for METOPROLOL SUCCINATE

Sponsor Name

Sponsor Name for METOPROLOL SUCCINATE
Sponsor Trials
Astellas Pharma Inc 24
Pfizer 22
GlaxoSmithKline 19
[disabled in preview] 19
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for METOPROLOL SUCCINATE
Sponsor Trials
Industry 219
Other 192
NIH 20
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Merck
Chinese Patent Office
Farmers Insurance
US Department of Justice
Dow
McKesson
Covington
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.